David Goeddel V

Filings by David Goeddel V span 3 companies, the busiest being NGM Biopharmaceuticals Inc, Tenaya Therapeutics, Inc. and RAPT Therapeutics, Inc. Over a trading history stretching from 8 April 2019 to 5 March 2025, the count stands at 164 filings.

Every open-market trade on record is a purchase: 141 purchases worth €148.3M, and no sale. The totals do not cover 6 filings with an undisclosed amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. So far in 2025, the count stands at 1 purchase and no sales.

The median purchase comes to €170k. 134 out of 137 purchases came within 30 days of a purchase by at least one other insider of the same company. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. For 5 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 80% of cases, with a median move of +58.0%. These figures describe past trades and do not predict future prices.

The newest entry dates from 7 March 2025: an open-market purchase of €23.5M, in Tenaya Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.